Cite
HARVARD Citation
Reijman, M. et al. (2022). Rationale and design of two trials assessing efficacy, safety and tolerability of Inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia. Atherosclerosis. pp. 150-. [Online].